Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)
China
· Delayed Price · Currency is CNY 64.30
-0.37 (-0.57%)
May 6, 2025, 2:45 PM CST
SHA:688399 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Operating Revenue | 331.36 | 380.05 | 4,336 | 2,340 | 1,505 | Upgrade
|
| Other Revenue | 18.25 | 23.13 | 1,199 | 499.11 | 235.03 | Upgrade
|
| Revenue | 349.61 | 403.18 | 5,535 | 2,839 | 1,740 | Upgrade
|
| Revenue Growth (YoY) | -13.29% | -92.72% | 94.95% | 63.19% | 502.39% | Upgrade
|
| Cost of Revenue | 147.64 | 253.94 | 2,380 | 879.96 | 390.72 | Upgrade
|
| Gross Profit | 201.97 | 149.24 | 3,155 | 1,959 | 1,349 | Upgrade
|
| Selling, General & Admin | 214.27 | 377.62 | 720.25 | 534.41 | 366.2 | Upgrade
|
| Research & Development | 100.52 | 135.39 | 185.32 | 106.35 | 70.36 | Upgrade
|
| Other Operating Expenses | -7.42 | -8.87 | 17.48 | -5.25 | -5.03 | Upgrade
|
| Operating Expenses | 270.92 | 533.52 | 981.87 | 648.43 | 437.99 | Upgrade
|
| Operating Income | -68.95 | -384.28 | 2,173 | 1,311 | 910.97 | Upgrade
|
| Interest Expense | -7.75 | -6.94 | -5.33 | -3.96 | -0.08 | Upgrade
|
| Interest & Investment Income | 39.78 | 57.56 | 42.74 | 26.83 | 7.77 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -2.74 | -0.69 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.1 | -1.19 | 0.76 | -1.53 | -1.54 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.49 | -0.16 | -0.33 | -3.33 | -0.26 | Upgrade
|
| EBT Excluding Unusual Items | -36.31 | -335.02 | 2,211 | 1,326 | 916.16 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.83 | 13.12 | 48.15 | 32.19 | 19.94 | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.07 | -2.92 | -1.44 | 2.97 | 4.56 | Upgrade
|
| Asset Writedown | -9.33 | -79.01 | -140.31 | - | - | Upgrade
|
| Other Unusual Items | 46.93 | 28.16 | 21.76 | 30.72 | 20.33 | Upgrade
|
| Pretax Income | 4.19 | -375.67 | 2,139 | 1,392 | 960.99 | Upgrade
|
| Income Tax Expense | 6.19 | -1.86 | 310.81 | 198.56 | 141.42 | Upgrade
|
| Net Income | -2 | -373.81 | 1,828 | 1,193 | 819.57 | Upgrade
|
| Net Income to Common | -2 | -373.81 | 1,828 | 1,193 | 819.57 | Upgrade
|
| Net Income Growth | - | - | 53.19% | 45.59% | 878.52% | Upgrade
|
| Shares Outstanding (Basic) | 67 | 59 | 59 | 59 | 59 | Upgrade
|
| Shares Outstanding (Diluted) | 67 | 59 | 59 | 59 | 59 | Upgrade
|
| Shares Change (YoY) | 13.88% | -0.06% | 0.03% | -0.02% | 29.48% | Upgrade
|
| EPS (Basic) | -0.03 | -6.38 | 31.18 | 20.36 | 13.98 | Upgrade
|
| EPS (Diluted) | -0.03 | -6.38 | 31.18 | 20.36 | 13.98 | Upgrade
|
| EPS Growth | - | - | 53.14% | 45.64% | 655.68% | Upgrade
|
| Free Cash Flow | 83.06 | -224.48 | 1,614 | 681.91 | 801.32 | Upgrade
|
| Free Cash Flow Per Share | 1.25 | -3.83 | 27.53 | 11.63 | 13.67 | Upgrade
|
| Dividend Per Share | - | - | - | 10.000 | 7.000 | Upgrade
|
| Dividend Growth | - | - | - | 42.86% | 366.67% | Upgrade
|
| Gross Margin | 57.77% | 37.02% | 56.99% | 69.01% | 77.54% | Upgrade
|
| Operating Margin | -19.72% | -95.31% | 39.26% | 46.16% | 52.36% | Upgrade
|
| Profit Margin | -0.57% | -92.72% | 33.03% | 42.03% | 47.11% | Upgrade
|
| Free Cash Flow Margin | 23.76% | -55.68% | 29.16% | 24.02% | 46.06% | Upgrade
|
| EBITDA | -19.59 | -315.5 | 2,256 | 1,344 | 933.05 | Upgrade
|
| EBITDA Margin | -5.60% | -78.25% | 40.76% | 47.35% | 53.63% | Upgrade
|
| D&A For EBITDA | 49.36 | 68.78 | 83.4 | 33.63 | 22.08 | Upgrade
|
| EBIT | -68.95 | -384.28 | 2,173 | 1,311 | 910.97 | Upgrade
|
| EBIT Margin | -19.72% | -95.31% | 39.26% | 46.16% | 52.36% | Upgrade
|
| Effective Tax Rate | 147.81% | - | 14.53% | 14.27% | 14.72% | Upgrade
|
| Revenue as Reported | 349.61 | 403.18 | 5,535 | 2,839 | 1,740 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.